Zhen Gu

Molecular Biology · 2015–2019

A researcher in the Science corpus: 5 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.

Subfields

Whom Zhen Gu trusts

Their strongest outbound trust, strongest first, inferred from their citations.

  1. Mark R. Prausnitz (in Molecular Biology)

Papers from Zhen Gu's perspective

Ordered by how strongly the researchers Zhen Gu trusts endorse each paper. Same corpus, a different order for every researcher.

  1. Type 2 diabetes: principles of pathogenesis and therapy (The Lancet)
  2. PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma (New England Journal of Medicine)
  3. The blockade of immune checkpoints in cancer immunotherapy (Nature Reviews. Cancer)
  4. Microfabricated needles for transdermal delivery of macromolecules and nanoparticles: Fabrication methods and transport studies (Proceedings of the National Academy of Sciences of the United States of America)
  5. Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised,… (The Lancet Oncology)
  6. Microneedles for transdermal drug delivery. (Advanced Drug Delivery Reviews)
  7. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma (New England Journal of Medicine)
  8. Programmed death ligand-1 expression in non-small cell lung cancer (Laboratory Investigation)
  9. Up-Regulation of PD-L1, IDO, and Tregs in the Melanoma Tumor Microenvironment Is Driven by CD8+ T Cells (Science Translational Medicine)
  10. Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma (Nature Medicine)

Their papers